ScottEDelacroixJr.MD

Urology • Metairie, LA

Surgical Oncology

Associate Professor Department of Urology Louisiana State University School of Medicine

Join to view full profile

Dr. Delacroix is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Delacroix's full profile

Already have an account?

Office
3601 Houma Blvd
Suite 301
Metairie, LA 70006
Phone+1 504-412-1600

Fax+1 504-412-1626

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Urologic Surgical Oncology, 2009 - 2012
Ochsner Clinic FoundationResidency, Urology, 2005 - 2009
Louisiana State University School of MedicineInternship, Transitional Year, 2004 - 2005
Louisiana State University School of Medicine in New OrleansClass of 2004

Certifications & Licensure

LA State Medical License 2006 - 2025
MS State Medical License 2024 - 2025
TX State Medical License 2009 - 2025
AL State Medical License 2024 - 2024
American Board of Urology Urology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013

Clinical Trials

Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Start of enrollment: 2018 Aug 01
Recruiting
Phase 2
A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes (The INSPIRE Study) Start of enrollment: 2021 Mar 17
Active, not recruiting
Phase 2
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery Start of enrollment: 2019 Apr 15
Active, not recruiting
Phase 2
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer Start of enrollment: 2019 Jun 03
Active, not recruiting
Phase 3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer Start of enrollment: 2018 Sep 24
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

26 citations
Comparison of Single-docking Robotic-assisted and Traditional Laparoscopy for Retroperitoneal Lymph Node Dissection During Nephroureterectomy With Bladder Cuff Excisio...
Jonathan Melquist, Grant P. Redrow, Scott E. Delacroix, Andrew Park, Eliney E. Faria
Urology. 2016-01-01
42 citations
Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?
Scott E. Delacroix, Brian F. Chapin, Jaclyn Jin-Ling Chen, Graciela M. Nogueras-Gonzalez, Pheroze Tamboli
The Journal of Urology. 2011-10-01
3 citations
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3...
Mohamad E Allaf, Se-Eun Kim, Viraj Master, David F McDermott, Lauren C Harshman
The Lancet. Oncology. 2024-08-01